GSK CEO addresses declining trust in vaccines following Trump re-election
Published on November 7, 2024
GSK PLC CEO, Emma Walmsley, recently spoke out about the declining trust in vaccines following the re-election of President Trump. In her statement, Walmsley emphasized the importance of vaccines in preventing the spread of diseases and maintaining public health. She reassured the public that GSK is committed to producing safe and effective vaccines, and urged individuals to trust in the scientific community and the rigorous regulatory processes in place. As the world continues to battle the COVID-19 pandemic, GSK remains dedicated to developing a vaccine that will help bring an end to this global crisis.
Investor opinions & comments
To leave a comment, you need to Login or Register.
GrowthGina
November 10, 2024 at 13:42
I appreciate GSK's commitment to producing safe and effective vaccines. Trust in the scientific community is crucial, especially during these uncertain times
EliWells
November 9, 2024 at 23:06
It's great to see GSK CEO addressing the declining trust in vaccines. I'm curious to learn more about the steps they are taking to ensure safety and effectiveness
ProfitPiper
November 9, 2024 at 21:00
With the speed at which the COVID-19 vaccine is being developed, can we truly trust its safety and long-term effects?
LucasPrice
November 9, 2024 at 16:15
I wonder if GSK will collaborate with other pharmaceutical companies to expedite the development of the COVID-19 vaccine
CapitalCathy
November 9, 2024 at 06:37
I'm not so sure about the trust in vaccines. We've seen controversies arise in the past, and I hope GSK's claims of safety and effectiveness are backed up by solid evidence
TraderTobias
November 8, 2024 at 00:36
I trust in the rigorous regulatory processes in place and I believe GSK will deliver a safe and effective vaccine. Let's support their efforts to end this global crisis